Trial intelligence / Profile preview

Conditioning to enhance pharmacotherapy in recent-onset rheumatoid arthritis

NL-OMON20702Recruiting

Sponsor
Leiden University
Start
Mar 2016
Countries
1
01

Overview

Trial in rheumatoid arthritis (RA) and autoimmune arthritis (2 arms), sponsored by Leiden University. Primary endpoint: Drug-free clinical remission after tapering. Started Mar 2016; status: recruiting.

02

Conditions

rheumatoid arthritis (RA)autoimmune arthritis

Beyond the preview

Go deeper on NL-OMON20702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call